enrasentan has been researched along with a 192621 in 1 studies
| Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (a 192621) | Trials (a 192621) | Recent Studies (post-2010) (a 192621) |
|---|---|---|---|---|---|
| 32 | 2 | 0 | 84 | 0 | 8 |
| Protein | Taxonomy | enrasentan (IC50) | a 192621 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.0051 | |
| Endothelin-1 receptor | Homo sapiens (human) | 9.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bochnowicz, S; Elliott, JD; Hart, TK; Hay, DW; Louden, CS; Luttmann, MA; Osborn, RR; Underwood, DC | 1 |
1 other study(ies) available for enrasentan and a 192621
| Article | Year |
|---|---|
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Topics: Altitude; Animals; Benzofurans; Carboxylic Acids; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Male; Propionates; Pulmonary Artery; Pyrrolidines; Random Allocation; Rats; Receptors, Endothelin | 1999 |